Non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations may undergo histological transformation into small-cell lung cancer (SCLC) as a mechanism of acquired resistance to EGFR-tyrosine kinase inhibitors (EGFR-TKIs). This evidence concerns the gene EGFR and non-small cell lung carcinoma.